|In stock (100)
|1-2 business days
Slightly invasive rapid test for the qualitative detection of viral SARS-CoV-2 nucleoproteins in human nasal, nasopharyngeal or oropharyngeal samples; Sampling by means of a short nasal swab (anterior nasal)
– Listed by the German Federal Institute for Drugs and Medical Devices (BfArM) –
The Dedicio® COVID-19 Ag plus test detects the virus directly by checking for the presence of specific SARS-CoV-2 proteins. Antigen detection thus closes a diagnostic gap. The nucleocapsid protein (N) is ideally suited for this detection, as it occurs very frequently in the virus and is sufficiently specific for SARS-CoV2. It is one of its 4 most important structural proteins and is involved in the replication, transcription and packaging of the viral genome.
Features of the test:
The Dedicio® COVID-19 Ag plus test is a chromatographic immunoassay in lateral flow format for the qualitative detection of viral SARS-CoV-2 nucleoproteins in human nasal, nasopharyngeal or oropharyngeal samples. The test is intended as an aid in diagnosing SARS-CoV-2 infections. It should be noted that the concentration of the viral nucleoprotein antigens can fluctuate during the course of the disease and can fall below the detection limit of the test. A possible infectiousness of the test persons cannot be excluded due to negative test results.
Dedicio® COVID-19 Ag plus Test / nal von minden:Rapid test for the qualitative in vitro determination of the Covid-19 antigen
in human nasal, nasopharyngeal or oropharyngeal specimens; specimen collection using a short nasal swab